The injectable neurotoxin drug candidate daxibotulinumtoxinA for injection (RT002, Revance Therapeutics) started phase 3 SAKURA trials in December 2016
Cellfina is subscision of the fibrous attachments between the skin and fat layers. It is the only FDA-cleared device to have solid three-year data showing that the cellulite doesn’t come back, expert says.
Fresh after her presentations on fat reduction and cellulite treatment devices at ASDS, Sue Ellen Cox, M.D., offers unplugged advice about today’s technologies.
The FDA announced it has approved Eucrisa (Anacor Pharmaceuticals, crisaborole) ointment to treat mild to moderate eczema in patients two-years-of-age and older.
Melanoma’s burden is increasing and the rising rates cannot simply be attributed to increased disease detection, according to a research letter published last month in JAMA Dermatology.
You might be surprised about what researchers have uncovered about why teens tan. Having a better understanding of their motives, could help you help them.
Several dermatologists go over what they're most excited about to see in 2017 in a number of different topics ranging from AD treatment to off-label technology use, to more male patients.
